DelfaGLP-1 Atlas

Lead sponsor

Shanghai 10th People's Hospital

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

0

Active

88

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1
Not applicable
1

Trials by status

Completed
1
Unknown
1

Trials led

GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)BMI ≥24Ph 4Completed68
Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory StatusFemalenot applicableUnknown20